You are currently viewing smoking;  One of the Causes of Increased Multiple Sclerosis in Women

The hormonal treatments and smoking are factors for the increased incidence of Multiple Sclerosis in women, disease that affects almost four times already more to the female population than to men.

This information was shared by Celia Oreja Guevara, section chief of the Multiple Sclerosis Unit of the Clinical Hospital of Madrid. This at the 38th ECTRIMS 2022 Congress, which brings together the main European experts on this disease between October 26 and 28 in Amsterdam.

According to Oreja, the increased incidence of the disease, and mainly in women, is due to environmental factors, such as smoking: “they smoke more than before and more than men“, as well as hormonal treatments, because “it is proven that the patient does better in pregnancy and much worse in menopause”.

Add to these factors the increase in women’s work the lack of exercise and having gone on to develop their activity from the field to indoors, which generates vitamin D deficiency, a determining cause of multiple sclerosis, together with genetic factors, the Epstein-Barr virus or obesity.

Treatments for multiple sclerosis

The Spanish neurologist has participated in a symposium on the relationship between “immune cells and inflammation of the central nervous system” in which treatment “as soon as possible” with cliadribin tablets has been assessed to improve the quality of life in people with sclerosis recurring multiple after two years of administration.

According to data from the phase IV trial presented at ECTRIMS 2022 with this drug, brain lesions detected by MRI are also maintained, as commented by Gavin Giovannoni, Professor of Neurology at Queen Mary University of London.

Giovannoni has influenced the administration of cliadribine tabletsfacilitates adherence to treatment and reduce the risk of generating infections by reducing the period of immunosuppression.

Sclerosis, Spain case

In Spain, with 55,000 people diagnosed with Multiple Sclerosis, this drug has been incorporated into the National Health System (SNS) since 2018 and is authorized for “all active patients”, as Oreja explains, noting that it is a treatment “by weight” and Allows personalization of patient care.

Each year they are diagnosed in Spain 2,000 new cases of multiple sclerosisa chronic autoimmune inflammatory disease of the Central Nervous System in which immune cells attack myelin (the protective covering that insulates nerve cells) damaging or destroying it and causing inflammation.

Regarding current treatments, Celia Oreja explained that they focus on reducing and reducing inflammation to improve the quality of life of patients; that “20 years ago they were all in a wheelchair”, although they do not stop the progression of the disease.

“What needs to be solved is how to stop this slow progression and repair the myelin that is lost”, insisted the neurologist, and highlighted that the diagnosis of the disease is getting shorter and shorter, which has gone from a year and a half to between two or three months in a decade.

Despite the symptoms that it produces are very varied – fatigue, balance and gait problems, numbness, tingling or vertigo- Oreja reveals that more and more patients are referred to neurology from Primary Care or the emergency room.

“Only the one who does not go to the doctor is the one we do not diagnose. Many times, he only feels tingling in one hand and does not go to a center, ”he warned.

With information from EFE



Disclaimer: If you need to update/edit/remove this news or article then please contact our support team Learn more

J. A. Allen

Author, blogger, freelance writer. Hater of spiders. Drinker of wine. Mother of hellions.

Leave a Reply